Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2015 Oct 30;290:107–115. doi: 10.1016/j.taap.2015.10.023

Figure 7.

Figure 7

The effects of treatment with SR140333, a peripheral NK1R antagonist (100 μg/kg) on the apneic response to capsaicin (CAP, 10 μg/kg) in Ctrl and PNE pups. SR140333 significantly shortens the PNE-induced prolongation of the apneic response to CAP with no effect on the CAP-induced apnea in Ctrl pups. Data present as Mean ± SE; N = 6 and 10 for Ctrl and PNE group. * and # P < 0.05 compared to Ctrl and PNE before the blockade respectively.